Simeon I. Taylor

24.0k total citations · 5 hit papers
194 papers, 14.7k citations indexed

About

Simeon I. Taylor is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Simeon I. Taylor has authored 194 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Molecular Biology, 84 papers in Surgery and 64 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Simeon I. Taylor's work include Pancreatic function and diabetes (81 papers), Metabolism, Diabetes, and Cancer (74 papers) and Diabetes and associated disorders (31 papers). Simeon I. Taylor is often cited by papers focused on Pancreatic function and diabetes (81 papers), Metabolism, Diabetes, and Cancer (74 papers) and Diabetes and associated disorders (31 papers). Simeon I. Taylor collaborates with scholars based in United States, Japan and Australia. Simeon I. Taylor's co-authors include Domenico Accili, Phillip Görden, Jenny E. Blau, Kristina I. Rother, Elif A Oral, Elif Arioǧlu, Valarie A. Barr, Takashi Kadowaki, Alex M. DePaoli and Abhimanyu Garg and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Simeon I. Taylor

193 papers receiving 14.3k citations

Hit Papers

Leptin-Replacement Therapy for Lipodystrophy 2002 2026 2010 2018 2002 2002 2002 2015 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Leptin-Replacement Therapy for Lipodystrophy
    2002 913 citations Elif A Oral, Alex M. DePaoli et al. profile →
  2. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
    2002 581 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
  3. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
    2002 503 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
  4. SGLT2 Inhibitors May Predispose to Ketoacidosis
    2015 396 citations Simeon I. Taylor, Jenny E. Blau et al. The Journal of Clinical Endocrinology & Metabolism profile →
  5. Pharmacological treatment of hyperglycemia in type 2 diabetes
    2021 167 citations Simeon I. Taylor, Amber L. Beitelshees et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simeon I. Taylor United States 65 8.5k 4.2k 4.1k 3.3k 2.4k 194 14.7k
C. Ronald Kahn United States 79 14.6k 1.7× 5.6k 1.3× 5.0k 1.2× 5.2k 1.6× 1.7k 0.7× 188 21.7k
Tomoichiro Asano Japan 69 10.3k 1.2× 4.1k 1.0× 2.7k 0.7× 2.9k 0.9× 1.5k 0.6× 313 17.8k
Y. Le Marchand‐Brustel France 59 7.6k 0.9× 2.5k 0.6× 1.7k 0.4× 3.5k 1.0× 756 0.3× 156 13.0k
Michael L. McDaniel United States 61 4.1k 0.5× 4.9k 1.1× 2.9k 0.7× 3.3k 1.0× 2.3k 1.0× 160 11.4k
W. Waldhäusl Austria 56 3.9k 0.5× 2.3k 0.5× 3.1k 0.8× 3.7k 1.1× 847 0.3× 268 11.0k
Joyce J. Repa United States 55 10.2k 1.2× 10.8k 2.6× 2.4k 0.6× 2.8k 0.8× 1.9k 0.8× 101 21.1k
Marten H. Hofker Netherlands 68 7.1k 0.8× 2.7k 0.6× 1.9k 0.5× 2.0k 0.6× 1.8k 0.7× 203 15.2k
Samuel W. Cushman United States 69 8.8k 1.0× 4.0k 0.9× 1.9k 0.5× 6.1k 1.8× 660 0.3× 191 14.7k
Donald A. McClain United States 64 6.4k 0.7× 2.3k 0.5× 1.5k 0.4× 2.7k 0.8× 891 0.4× 166 11.5k
Terry G. Unterman United States 62 7.3k 0.9× 1.7k 0.4× 2.6k 0.6× 2.5k 0.7× 1.2k 0.5× 157 12.6k

Countries citing papers authored by Simeon I. Taylor

Since Specialization
Citations

This map shows the geographic impact of Simeon I. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeon I. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeon I. Taylor more than expected).

Fields of papers citing papers by Simeon I. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simeon I. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeon I. Taylor. The network helps show where Simeon I. Taylor may publish in the future.

Co-authorship network of co-authors of Simeon I. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Simeon I. Taylor. A scholar is included among the top collaborators of Simeon I. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simeon I. Taylor. Simeon I. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, Rajiv P., Billy I. Kim, Alexander E. White, et al.. (2025). Glucagon-like peptide-1 receptor agonist use is not associated with reduced postoperative complications in obese patients after total shoulder arthroplasty. Seminars in Arthroplasty JSES. 35(4). 591–598.
2.
Beitelshees, Amber L., Elizabeth A. Streeten, Hilary B. Whitlatch, et al.. (2024). Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in oral glucose tolerance test. Clinical and Translational Science. 17(5). e13809–e13809. 1 indexed citations
3.
Chao, Ariana M., et al.. (2024). Evolving Approaches for Pharmacological Therapy of Obesity. The Annual Review of Pharmacology and Toxicology. 65(1). 169–189. 6 indexed citations
4.
Streeten, Elizabeth A., et al.. (2023). Vitamin D Deficiency Increases Vulnerability to Canagliflozin-induced Adverse Effects on 1,25-Dihydroxyvitamin D and PTH. The Journal of Clinical Endocrinology & Metabolism. 109(2). e646–e656. 3 indexed citations
5.
Taylor, Simeon I., May E. Montasser, Hilary B. Whitlatch, et al.. (2023). Pharmacogenetics of sodium‐glucose co‐transporter‐2 inhibitors: Validation of a sex‐agnostic pharmacodynamic biomarker. Diabetes Obesity and Metabolism. 25(12). 3512–3520. 3 indexed citations
6.
Blau, Jenny E., Viviana Bauman, Paolo Piaggi, et al.. (2018). Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 3(8). 118 indexed citations
7.
Blau, Jenny E., Sri Harsha Tella, Simeon I. Taylor, & Kristina I. Rother. (2017). Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes/Metabolism Research and Reviews. 33(8). 169 indexed citations
8.
Sun, Xiao‐Jian, Qi Cao, Xin Lü, et al.. (2017). Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle. Journal of Biological Chemistry. 292(29). 12339–12350. 23 indexed citations
9.
Taylor, Simeon I., Jenny E. Blau, & Kristina I. Rother. (2014). Possible adverse effects of SGLT2 inhibitors on bone. The Lancet Diabetes & Endocrinology. 3(1). 8–10. 214 indexed citations
10.
LeRoith, Derek, Simeon I. Taylor, & Jerrold M. Olefsky. (2004). Diabetes mellitus : a fundamental and clinical text. Lippincott Williams & Wilkins eBooks. 410 indexed citations
11.
Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 44 indexed citations
12.
Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 503 indexed citations breakdown →
13.
Attersand, Anneli, S. Lake, Simin Liu, et al.. (2002). Absence of functional insulin receptor substrate-3 ( IRS-3 ) gene in humans. Diabetologia. 45(12). 1697–1702. 79 indexed citations
14.
Speckman, Rebecca A., Abhimanyu Garg, Fenghe Du, et al.. (2000). Mutational and Haplotype Analyses of Families with Familial Partial Lipodystrophy (Dunnigan Variety) Reveal Recurrent Missense Mutations in the Globular C-Terminal Domain of Lamin A/C. The American Journal of Human Genetics. 66(4). 1192–1198. 228 indexed citations
15.
Zhou, Lixin, Hui Chen, Pin Xu, et al.. (1999). Action of Insulin Receptor Substrate-3 (IRS-3) and IRS-4 to Stimulate Translocation of GLUT4 in Rat Adipose Cells. Molecular Endocrinology. 13(3). 505–514. 53 indexed citations
16.
Barr, Valarie A., Daniela Malide, Mary Jane Zarnowski, Simeon I. Taylor, & Samuel W. Cushman. (1997). Insulin Stimulates Both Leptin Secretion and Production by Rat White Adipose Tissue. Endocrinology. 138(10). 4463–4472. 242 indexed citations
17.
Quon, Michael J., Hui Chen, Mary Jane Zarnowski, et al.. (1995). Roles of 1-Phosphatidylinositol 3-Kinase and ras in Regulating Translocation of GLUT4 in Transfected Rat Adipose Cells. Molecular and Cellular Biology. 15(10). 5403–5411. 130 indexed citations
18.
Quon, Michael J., Atul J. Butte, & Simeon I. Taylor. (1994). Insulin signal transduction pathways. Trends in Endocrinology and Metabolism. 5(9). 369–376. 37 indexed citations
19.
Taylor, Simeon I., et al.. (1990). Mutations of the human insulin receptor gene. Trends in Endocrinology and Metabolism. 1(3). 134–139. 8 indexed citations
20.
Gorden, D. Lee, A Robert, Victoria Moncada, et al.. (1990). Cell Surface Alteration in Epstein-Barr Virus-Transformed Cells From Patients With Extreme Insulin Resistance. Diabetes. 39(8). 924–927. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Ronald Kahn Breakdown of academic impact, for papers by Tomoichiro Asano Breakdown of academic impact, for papers by Y. Le Marchand‐Brustel Breakdown of academic impact, for papers by Michael L. McDaniel Breakdown of academic impact, for papers by W. Waldhäusl Breakdown of academic impact, for papers by Joyce J. Repa Breakdown of academic impact, for papers by Marten H. Hofker Breakdown of academic impact, for papers by Samuel W. Cushman Breakdown of academic impact, for papers by Donald A. McClain Breakdown of academic impact, for papers by Terry G. Unterman
Rankless by CCL
2026